OxAgeN - the Oxford Ageing Network

OxAgeN

COVID-19:

Global data show that older people are hit the hardest by the new SARS-CoV-2 virus that causes COVID-19.  

It is vital that efforts to develop new treatments for COVID-19 factor in ageing and in particular how older people’s immune systems differ from those of younger people. Biogerontology, or the study of the biology of ageing, has helped to highlight ways in which it should be possible to strengthen the body's ability to fight off the virus without going into overdrive, called 'cytokine storm', that can result in critical illness and death. We are working with colleagues around the world to bring this research to the clinic to try to help fight the pandemic. If you feel your research is relevant to this endeavour, please contact us through the link in the COVID-19 action box (below).

 

We aim to bring together researchers with an interest in ageing and promoting better health in later life. The group encompasses basic and translational scientists, clinicians and social scientists within (but not restricted to) Oxford. We will run three networking meetings a year and provide a forum for free exchange of ideas and novel findings to promote rapid progress in ageing.

Membership is open to those within the University of Oxford and Oxford Brookes University, as well as the Oxford University Hospitals Trusts and local clinical practices. We are non-hierarchical and welcome students and staff. 

Why Oxford?

Biological ageing research in Oxford encompasses every step along the ageing pathway, from understanding the individual genes and proteins involved, to model organism studies of longevity and healthspan, through to disease models and human clinical trials. As well as biological and clinical research on ageing, social and economic impacts of ageing are well-studied (Oxford Ageing Institute), as are ethical considerations and future strategies (Oxford Martin School). Whilst spread over a number of Departments throughout the University, there is an integrated approach to ageing research with inter-lab collaborations, and major network initiatives such as OXDARE and most recently OxAgeN. Those working on the basic biology of ageing benefit from a wealth of expertise from related labs working on development, neurobiology, stem cells and cancer, together with support from structural biophysics, proteomics, computational modelling, systems biology and ultra high resolution microscopy, and access to the Diamond light source, the Harwell Ageing Screen, the Structural Genomics Consortium and the Target Discovery Institute. This combination of world class expertise makes Oxford a vibrant centre for ageing research. 

Contact us

For more information, email lynne.cox@bioch.ox.ac.uk